Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285085598> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4285085598 abstract "Abstract Background Breast cancer is the most frequent cancer in women worldwide. Most breast cancer cases are estrogen receptor positive and epidermal growth factor receptor 2 negative (ER+/HER2-). A small proportion of these cases are metastatic, with Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors being the mainstay of treatment in this scenario. Evidence supports the existence of differences between the three approved cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in preclinical and clinical settings. However, literature regarding the use of a CDK4/6i in metastatic breast cancer patients (MBC) previously treated with another CDK4/6i is scarce. Methods A search will be performed on the PubMed, Embase, and Web of Science databases following Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. In addition, a manual search of the San Antonio Breast Cancer Conference, American Society of Clinical Oncology annual conference, European Society of Medical Oncology annual conference, and European Society of Medical Oncology Breast annual conference will be performed. Discussion To our knowledge, no previous systematic review has evaluated the available evidence regarding the efficacy and safety of treatment with CDK4/6i in MBC previously treated with another CDK4/6i. This systematic review and meta-analysis will synthesise the existing data on the effectiveness and safety of using a CDK4/6i after prior exposure to another in MBC. It will also identify the gap in the literature for potential future research. This study's results will interest multiple audiences, including patients, their families, caregivers, and healthcare professionals. Results will be published in a peer-reviewed journal. Systematic review registration: PROSPERO CRD42022330355" @default.
- W4285085598 created "2022-07-14" @default.
- W4285085598 creator A5010532746 @default.
- W4285085598 creator A5022744007 @default.
- W4285085598 creator A5030949201 @default.
- W4285085598 creator A5033909513 @default.
- W4285085598 creator A5036795234 @default.
- W4285085598 creator A5056268274 @default.
- W4285085598 creator A5059383103 @default.
- W4285085598 creator A5061030816 @default.
- W4285085598 creator A5073103314 @default.
- W4285085598 creator A5084038731 @default.
- W4285085598 date "2022-07-13" @default.
- W4285085598 modified "2023-10-16" @default.
- W4285085598 title "Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysis" @default.
- W4285085598 doi "https://doi.org/10.21203/rs.3.rs-1796416/v2" @default.
- W4285085598 hasPublicationYear "2022" @default.
- W4285085598 type Work @default.
- W4285085598 citedByCount "0" @default.
- W4285085598 crossrefType "posted-content" @default.
- W4285085598 hasAuthorship W4285085598A5010532746 @default.
- W4285085598 hasAuthorship W4285085598A5022744007 @default.
- W4285085598 hasAuthorship W4285085598A5030949201 @default.
- W4285085598 hasAuthorship W4285085598A5033909513 @default.
- W4285085598 hasAuthorship W4285085598A5036795234 @default.
- W4285085598 hasAuthorship W4285085598A5056268274 @default.
- W4285085598 hasAuthorship W4285085598A5059383103 @default.
- W4285085598 hasAuthorship W4285085598A5061030816 @default.
- W4285085598 hasAuthorship W4285085598A5073103314 @default.
- W4285085598 hasAuthorship W4285085598A5084038731 @default.
- W4285085598 hasBestOaLocation W42850855981 @default.
- W4285085598 hasConcept C121608353 @default.
- W4285085598 hasConcept C126322002 @default.
- W4285085598 hasConcept C143998085 @default.
- W4285085598 hasConcept C17744445 @default.
- W4285085598 hasConcept C189708586 @default.
- W4285085598 hasConcept C199539241 @default.
- W4285085598 hasConcept C2775930923 @default.
- W4285085598 hasConcept C2779473830 @default.
- W4285085598 hasConcept C2779744173 @default.
- W4285085598 hasConcept C29537977 @default.
- W4285085598 hasConcept C51853150 @default.
- W4285085598 hasConcept C530470458 @default.
- W4285085598 hasConcept C71924100 @default.
- W4285085598 hasConcept C82495950 @default.
- W4285085598 hasConcept C95190672 @default.
- W4285085598 hasConceptScore W4285085598C121608353 @default.
- W4285085598 hasConceptScore W4285085598C126322002 @default.
- W4285085598 hasConceptScore W4285085598C143998085 @default.
- W4285085598 hasConceptScore W4285085598C17744445 @default.
- W4285085598 hasConceptScore W4285085598C189708586 @default.
- W4285085598 hasConceptScore W4285085598C199539241 @default.
- W4285085598 hasConceptScore W4285085598C2775930923 @default.
- W4285085598 hasConceptScore W4285085598C2779473830 @default.
- W4285085598 hasConceptScore W4285085598C2779744173 @default.
- W4285085598 hasConceptScore W4285085598C29537977 @default.
- W4285085598 hasConceptScore W4285085598C51853150 @default.
- W4285085598 hasConceptScore W4285085598C530470458 @default.
- W4285085598 hasConceptScore W4285085598C71924100 @default.
- W4285085598 hasConceptScore W4285085598C82495950 @default.
- W4285085598 hasConceptScore W4285085598C95190672 @default.
- W4285085598 hasLocation W42850855981 @default.
- W4285085598 hasOpenAccess W4285085598 @default.
- W4285085598 hasPrimaryLocation W42850855981 @default.
- W4285085598 hasRelatedWork W2769683585 @default.
- W4285085598 hasRelatedWork W2912763149 @default.
- W4285085598 hasRelatedWork W2971679304 @default.
- W4285085598 hasRelatedWork W3038454317 @default.
- W4285085598 hasRelatedWork W3081950012 @default.
- W4285085598 hasRelatedWork W3092326212 @default.
- W4285085598 hasRelatedWork W3203106735 @default.
- W4285085598 hasRelatedWork W3203690439 @default.
- W4285085598 hasRelatedWork W4366351020 @default.
- W4285085598 hasRelatedWork W4368343477 @default.
- W4285085598 isParatext "false" @default.
- W4285085598 isRetracted "false" @default.
- W4285085598 workType "article" @default.